35.6% of Pfizer Vaccine Recipients Developed Fevers after 2nd Shot, Higher Incidence in Women: MHLW

MHLW's Joint Safety Panel Meetings on March 26 Over 35% of healthcare professionals who received Pfizer/BioNTech’s COVID-19 vaccine in Japan’s initial inoculation program developed fevers after getting their second shot, according to the interim results of a health ministry-funded cohort...read more